Alex Sapir - 01 Jul 2023 Form 3 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role: President & Chief Executive Officer Exhibit Index: 24.1 Power of Attorney, Director
Signature: /s/ Gregory Tourangeau as attorney-in-fact for Alex Sapir
Issuer symbol: FULC
Transactions as of: 01 Jul 2023
Net transactions value: $0
Form type: 3
Filing time: 03 Jul 2023, 16:16:20 UTC
Previous filing: 19 May 2023
Next filing: 05 Mar 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	FULC	Stock Option (right to buy)							01 Jul 2023	Common Stock	2,430,400	$3.27	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on May 12, 2023 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of May 12, 2023. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.

Remarks:

President & Chief Executive Officer Exhibit Index: 24.1 Power of Attorney